Cemiplimab treatment of recurrent cervical cancer is associated with longer overall survival
Physician's Weekly,
1. Overall survival is longer in patients treated with cemiplimab as compared to chemotherapy. 2. Fewer adverse effects are…
Evidence-Based Treatment Paradigms for Management of Invasive Cervical Carcinoma.
Overview of attention for article published in Journal of Clinical Oncology, August 2019
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
Good Attention Score compared to outputs of the same age and source (65th percentile)
Readers on
- mendeley
- 62 Mendeley